Related Experiment Videos
Adenosine deaminase activity in leprosy (a preliminary study).
S D Chaudhary1, V Gupta, A S Saini
1Department of Dermatology and Venereology, Medical College, Rohtak.
Indian Journal of Leprosy
|January 1, 1988
Summary
Adenosine deaminase (ADA) activity significantly increased in leprosy patients across various forms, including BL, LL, and BT, compared to healthy individuals. This finding highlights ADA as a potential biomarker for leprosy.
Area of Science:
- Immunology
- Biochemistry
- Infectious Diseases
Background:
- Leprosy is a chronic infectious disease primarily affecting the skin and peripheral nerves.
- Adenosine deaminase (ADA) is an enzyme involved in purine metabolism and immune function.
- Altered enzyme activity can indicate disease states.
Purpose of the Study:
- To investigate the activity of adenosine deaminase (ADA) in patients with different forms of leprosy.
- To compare ADA levels between leprosy patients and healthy controls.
Main Methods:
- Collected blood samples from 25 leprosy patients (various types) and 25 healthy volunteers.
- Measured adenosine deaminase (ADA) activity in all participants.
- Performed statistical analysis to compare ADA levels.
Main Results:
- Significantly elevated ADA activity was observed in leprosy patients: BL (72.9 +/- 6.85), LL (56.7 +/- 3.35), and BT (39.1 +/- 8.28).
- Healthy controls showed a mean ADA activity of 9.7 +/- 0.53.
- The increase in ADA activity in leprosy patients was statistically significant compared to controls.
Conclusions:
- Leprosy is associated with a significant elevation in adenosine deaminase (ADA) activity.
- ADA may serve as a useful biomarker for diagnosing and monitoring leprosy.
- Further research could explore ADA's role in the immunopathology of leprosy.